An official website of the United States government
Here's how you know
A .mil website belongs to an official U.S. Department of Defense organization in the United States.
A lock (lock ) or https:// means you’ve safely connected to the .mil website. Share sensitive information only on official, secure websites.


NEWS | Sept. 18, 2023

Army AL&T Feature - Expedited Delivery

By Meg Holahan, Alex Hillman, Kelly Burkhalter, JPEO-CBRND Public Affairs

The naloxone autoinjector is a rescue treatment that will counteract the adverse effects from exposure to opioids and allows impacted service members to remain ambulatory to move to higher levels of care. (Photo provided courtesy of Kaléo, Inc.)

Read the full article about how the JPEO-CBRND filled a gap in Europe with rapid delivery of a lifesaving antidote -


Download our press kit, which includes helpful documents to better understand our work, such as – Command Brief, Chemical Biological Defense Program's Enterprise strategy, the JPEO-CBRND's Capabilities Catalog, Leadership Biographies, COVID-19 fact sheets, and contracting overview documents.  



JPEO-CBRND Public Affairs Office

The JPEO-CBRND Public Affairs Office coordinates and responds to all public affairs and media relations needs on behalf of the JPEO-CBRND. To request a speaker, subject matter expert, or for other interview or request for comment please email our Public Affairs Office email below.